title: Targeting the effects of omega-3 and omega-6 fatty acid supplementation on schizophrenic spectrum disorders: role of neuroimaging.
authors.forename: M
authors.initials: M
authors.lastname: Sota
authors.forename: C
authors.initials: C
authors.lastname: Allegri
authors.forename: M
authors.initials: M
authors.lastname: Cortesi
authors.forename: F
authors.initials: F
authors.lastname: Barale
authors.forename: P
authors.initials: P
authors.lastname: Politi
authors.forename: P
authors.initials: P
authors.lastname: Fusar-Poli
mesh_terms: D001921:Brain / Q000378:metabolism* / Q000503:physiopathology; D019587:Dietary Supplements; D016503:Drug Delivery Systems; D015525:Fatty Acids, Omega-3 / Q000008:administration & dosage* / Q000502:physiology; D043371:Fatty Acids, Omega-6 / Q000008:administration & dosage* / Q000502:physiology; D006801:Humans; D008279:Magnetic Resonance Imaging; D012559:Schizophrenia / Q000175:diagnosis / Q000178:diet therapy* / Q000378:metabolism*
chemical_list: D015525:Fatty Acids, Omega-3; D043371:Fatty Acids, Omega-6